# Livzon Group (Ningxia) Pharmaceutical Co., Ltd. – FDA Inspection, Oct 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/a82b46fe-c65c-416b-a72d-567fb166f2f3
Source feed: FDA_Inspections

> FDA inspection 1070291 of Livzon Group (Ningxia) Pharmaceutical Co., Ltd., October 19, 2018. Classification: Official Action Indicated (OAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070291
- Company Name: Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
- Inspection Date: 2018-10-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1286526 - 2025-09-05](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/851f62b2-0417-46fb-a423-77ac6fae1dd7)
- FDA Inspection 1115730 - 2019-12-06
- [FDA Inspection 998978 - 2017-01-13](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/b3c7fe6a-532f-4d1a-9777-125f9bdba24d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joel-d-hustedt/29440042-08dd-4dce-be48-b55f8e1d7080)

Company: https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
